<DOC>
	<DOCNO>NCT01345734</DOCNO>
	<brief_summary>This trial conduct Asia . The aim trial investigate safety profile liraglutide normal condition use .</brief_summary>
	<brief_title>Non-Interventional Study Safety Liraglutide Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Subjects type 2 diabetes mellitus , include newlydiagnosed subject already receive antidiabetic medication include GLP1 analogue Liraglutide , require treatment liraglutide accord clinical judgment treat physician Subjects capable give studyspecific sign informed consent collection information Subjects type 1 diabetes Subjects previously liraglutide Subjects participate another clinical trial Subjects hypersensitivity liraglutide excipients ( Disodium phosphate dihydrate , propylene glycol , phenol , water injection ) Subjects pregnant , breast feeding intention become pregnant within follow 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>